EX-12.1 2 a08-25331_1ex12d1.htm EX-12.1

EXHIBIT 12.1

 

United Therapeutics Corporation
Ratio of Earnings to Fixed Charges
(Unaudited)

 

 

 

Nine
Months
Ended
September 30,

 

Years Ended December 31,

 

 

 

2008

 

2007

 

2006

 

2005

 

2004

 

 

 

(in thousands, except ratio)

 

Earnings from continuing operations before fixed charges

 

$

38,356

 

$

19,859

 

$

28,928

 

$

42,893

 

$

13,209

 

Fixed charges:

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net of capitalized interest

 

$

—

 

$

2,175

 

$

482

 

$

29

 

$

3

 

Capitalized interest

 

2,132

 

689

 

—

 

—

 

—

 

Portion of rentals representative of interest factor

 

891

 

1,885

 

1,172

 

—

 

—

 

Total fixed charges

 

3,023

 

4,749

 

1,654

 

29

 

3

 

Ratio of earnings to fixed charges

 

12.69

 

4.18

 

17.49

 

1,479.07

 

4,403.00

 

Excess fixed charges over earnings

 

$

—

 

$

—

 

$

—

 

$

—

 

—

 

 

NOTE:  The Ratio of Earnings to Fixed Charges should be read in conjunction with the Consolidated Financial Statements and related Notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations in United Therapeutics Corporation’s Annual Report on Form 10-K for the year ended December 31, 2007, and the Quarterly Report on Form 10-Q for the nine months ended September 30, 2008.

 

1